Advanced Search

Revoke Authorisation Upon Renunciation, Commerciodel Medicinal Product For Human Use "dorzolamide Bausch & Lomb».

Original Language Title: Revoca, su rinuncia, dell'autorizzazione all'immissione in commerciodel medicinale per uso umano «Dorzolamide Bausch & Lomb».

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
With no aRM-67/2015-1499 of March 10, 2015 's revoked, pursuant to art. 38, paragraph 9, of the Legislative Decree of April 24, 2006, no. 219, on renunciation of Bausch & LOMB-IOM S.P.A. the marketing authorisation for the medicinal product in the boxes indicated below: Medicine: DORZOLAMIDE BAUSCH & LOMB.
Package: A.I.C. # 040984039.
Description: "20 mg/ml eye drops from 5 ml 6 bottles LDPE".
Medicine: DORZOLAMIDE BAUSCH & LOMB.
Package: A.I.C. # 040984027.
Description: "20 mg/ml eye drops 5 ml LDPE bottles from 3 '.
Medicine: DORZOLAMIDE BAUSCH & LOMB.
Package: A.I.C. # 040984015.
Description: "20 mg/ml eye drops, solution 1 vial 5 ml LDPE from '.
If the distribution channel were present stocks of medicine revoked, in the course of validity, the same will be disposed of not later than 180 days after the date of publication of this determination.